congenital myasthenic syndrome

GPTKB entity

Statements (87)
Predicate Object
gptkbp:instanceOf gptkb:disease
muscular dystrophy
gptkbp:affects neuromuscular junction
gptkbp:associatedWith gptkb:ITGB1
gptkb:ITGAL
gptkb:COL13A1
gptkb:ITGAM
gptkb:ITGB2
gptkb:ITGAE
gptkb:LAMB2
gptkb:LAMA2
CHAT
ITGB3
ITGB4
ITGB5
ITGB6
ITGB7
ITGB8
SCN4A
CHRNE
COLQ
AGRN
ALG14
ALG2
B3GALNT2
B3GNT1
DAG1
DOK7
DPAGT1
DPM1
DPM2
DPM3
FKRP
FKTN
GFPT1
GMPPB
ISPD
ITGA10
ITGA11
ITGA2
ITGA3
ITGA5
ITGA6
ITGA7
ITGA8
ITGA9
ITGAV
ITGBL1
LARGE1
LARGE2
MUSK
POMGNT1
POMGNT2
POMK
POMT1
POMT2
PREPL
RAPSN
SGCA
SGCB
SGCD
SGCG
SLC5A7
TOR1AIP1
gptkbp:causedBy genetic disorder
gptkbp:distinctFrom gptkb:myasthenia_gravis
gptkbp:hasOrphanetID ORPHA:590
https://www.w3.org/2000/01/rdf-schema#label congenital myasthenic syndrome
gptkbp:ICD-10_code gptkb:G70.3
gptkbp:inheritance autosomal dominant
autosomal recessive
gptkbp:MeSH_ID D020521
gptkbp:OMIM 254210
gptkbp:onset childhood
congenital
gptkbp:symptom muscle weakness
ptosis
fatigability
ophthalmoplegia
respiratory difficulties
gptkbp:treatment gptkb:ephedrine
gptkb:3,4-diaminopyridine
gptkb:salbutamol
acetylcholinesterase inhibitors
gptkbp:bfsParent gptkb:VAMP1
gptkb:COL13A1
gptkbp:bfsLayer 7